Dr. Rizack is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
795 Middle St
Fall River, MA 02721Phone+1 508-235-5226
Education & Training
- Brown UniversityFellowship, Hematology and Medical Oncology, 2007 - 2010
- University of ChicagoResidency, Internal Medicine, 1999 - 2002
- University of ChicagoInternship, Transitional Year, 1998 - 1999
- Emory University School of MedicineClass of 1998
Certifications & Licensure
- MA State Medical License 2003 - 2026
- RI State Medical License 2002 - 2026
- IL State Medical License 1998 - 2002
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer.(MONALEESA-2) Start of enrollment: 2013 Dec 17
Publications & Presentations
PubMed
- 19 citationsSurvival of Patients with Squamous Cell Malignancies of the Upper Urinary TractDavid Berz, Tina Rizack, Sherry Weitzen, Anthony Mega, Joseph Renzulli
Clinical Medicine Insights. Oncology. 2012-01-01 - 75 citationsMedical Marijuana Use in Oncology: A ReviewGianna Wilkie, Bachir J. Sakr, Tina Rizack
JAMA Oncology. 2016-05-01 - 63 citationsA phase 2, randomized, double-blind, placebo- controlled study of chemo-immunotherapy combination using motolimod with pegylated liposomal doxorubicin in recurrent or ...Bradley J. Monk, Mark F. Brady, Carol Aghajanian, Heather A. Lankes, Tina Rizack
Annals of Oncology. 2017-05-01
Press Mentions
- CME Information - May 2018January 28th, 2018
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: